UPDATED 20.02.2014 13:22

Organised cervical cancer screening programme in the Oulu region in Finland in the invitation year 2011. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 23916 162 0.68 1 0.00 1 0.00 1 0.00 30 0.13 19 0.08 15 0.06 95 0.40
I 23209 1 - - - - - - - - - - - - - 1 -
II 453 61 0.26 - - - - - - - - 1 - 6 0.03 54 0.23
III 89 89 0.37 1 - 1 - 1 - 24 0.10 15 0.06 7 0.03 40 0.17
IV 11 11 0.05 - - - - - - 6 0.03 3 0.01 2 0.01 - -
V - - - - - - - - - - - - - - - - -
Inadequate - - - - - - - - - - - - - - - - -
Unknown 154 - - - - - - - - - - - - - - - -
HPV test 160 13 8.13 - - - - - - 1 0.63 1 0.63 1 0.63 10 6.25
Negative1 142 - - - - - - - - - - - - - - - -
Positive2 18 13 8.13 - - - - - - 1 0.63 1 0.63 1 0.63 10 6.25
Total 24076 175 0.73 1 0.00 1 0.00 1 0.00 31 0.13 20 0.08 16 0.07 105 0.44

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.